By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Illumina today postponed the release of its fourth-quarter and full-year 2011 financial results as its board reviews Roche's $5.7 million hostile bid for the San Diego-based next-generation sequencing and microarray firm.
Registering provides access to this and other free content.
Already have an account?Login Now.
George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.
A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.
The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.
In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.